Cargando…
Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes
BACKGROUND: Patients with cancer‐associated thrombosis (CAT) have a high risk of recurrent venous thromboembolic events, which contribute to significant morbidity and mortality. Direct oral anticoagulants may provide a convenient treatment option for these patients. OBJECTIVES: To assess clinical ch...
Autores principales: | Maraveyas, Anthony, Beyer‐Westendorf, Jan, Lee, Agnes Y., Mantovani, Lorenzo G., De Sanctis, Yoriko, Abdelgawwad, Khaled, Fatoba, Samuel, Bach, Miriam, Cohen, Alexander T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633229/ https://www.ncbi.nlm.nih.gov/pubmed/34877446 http://dx.doi.org/10.1002/rth2.12604 |
Ejemplares similares
-
Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study)
por: Picker, Nils, et al.
Publicado: (2021) -
COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study
por: Cohen, Alexander T., et al.
Publicado: (2018) -
Rationale and design for Lowering-hyperUricaemia treatment on cardiovascular outcoMes In peritoNeal diAlysis patients: a prospective, multicentre, double-blind, randomised controlled trial (LUMINA)
por: Chen, Wei, et al.
Publicado: (2020) -
The Public Libary of Renaissance Florence. Niccolò Niccoli, Cosimo de Medici and the Library of San Marco
Publicado: (1977) -
" Mes découvertes ont dépassé mes attentes"
por: Rey, P
Publicado: (1999)